HomeCompareCHBAY vs MRK

CHBAY vs MRK: Dividend Comparison 2026

CHBAY yields 2.35% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CHBAY wins by $131.92M in total portfolio value· pulled ahead in Year 2
10 years
CHBAY
CHBAY
● Live price
2.35%
Share price
$65.00
Annual div
$1.53
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$131.97M
Annual income
$122,014,828.99
Full CHBAY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CHBAY vs MRK

📍 CHBAY pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCHBAYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CHBAY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CHBAY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CHBAY
Annual income on $10K today (after 15% tax)
$200.08/yr
After 10yr DRIP, annual income (after tax)
$103,712,604.64/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, CHBAY beats the other by $103,704,276.23/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CHBAY + MRK for your $10,000?

CHBAY: 50%MRK: 50%
100% MRK50/50100% CHBAY
Portfolio after 10yr
$66.01M
Annual income
$61,012,313.57/yr
Blended yield
92.42%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CHBAY
No analyst data
Altman Z
0.3
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CHBAY buys
0
MRK buys
0
No recent congressional trades found for CHBAY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCHBAYMRK
Forward yield2.35%2.76%
Annual dividend / share$1.53$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$131.97M$56.8K
Annual income after 10y$122,014,828.99$9,798.13
Total dividends collected$131.20M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CHBAY vs MRK ($10,000, DRIP)

YearCHBAY PortfolioCHBAY Income/yrMRK PortfolioMRK Income/yrGap
1$11,171$470.77$11,206$366.19$35.00MRK
2← crossover$12,936$982.96$12,650$502.35+$286.00CHBAY
3$15,969$2,127.60$14,407$694.19+$1.6KCHBAY
4$21,996$4,909.29$16,585$967.82+$5.4KCHBAY
5$36,175$12,639.63$19,342$1,363.89+$16.8KCHBAY
6$77,563$38,855.32$22,913$1,947.19+$54.6KCHBAY
7$238,710$155,718.05$27,662$2,823.89+$211.0KCHBAY
8$1,151,203$895,782.77$34,159$4,173.35+$1.12MCHBAY
9$9,306,547$8,074,760.24$43,337$6,308.80+$9.26MCHBAY
10$131,972,834$122,014,828.99$56,776$9,798.13+$131.92MCHBAY

CHBAY vs MRK: Complete Analysis 2026

CHBAYStock

The Chiba Bank, Ltd., together with its subsidiaries, provides banking products and services in Japan and internationally. It offers various deposit products; and various loans and bills discounting products, as well as investment management and investment advisory services. The company also engages in securities, leasing, credit card, and credit guarantee business; management and collection of claims; and outsourcing of operational business. In addition, it rents and maintains office buildings and welfare facilities; purchases and sells supplies and consumer goods; and develops and sells software, and commissioned computation tasks. Further, the company provides housing loan guarantees and fee collection services; information, survey, and consulting services; and accounting, general administration entrustment, and temporary staff services. Additionally, it engages in the research and investigation of IT and financial technologies; and operation and management of investment funds, and M&A advisory services. The company serves individuals, and small and mid-sized enterprises. As of June 25, 2021, it operated 186 domestic offices, including 183 branches and 3 money exchange counters; 3 overseas branches in New York, Hong Kong, and London; and 3 overseas representative offices in Shanghai, Singapore, and Bangkok. The company was incorporated in 1943 and is headquartered in Chiba, Japan.

Full CHBAY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CHBAY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CHBAY vs SCHDCHBAY vs JEPICHBAY vs OCHBAY vs KOCHBAY vs MAINCHBAY vs JNJCHBAY vs ABBVCHBAY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.